Methods of Care

Tuesday, October 26, 2021: 5:00 PM-7:00 PM
Exhibit Hall (Rosen Shingle Creek)
MOC01
Impact of the COVID-19 Pandemic on People with Multiple Sclerosis: Results from an International Survey
Alana T Wong, PhD, Sanofi; Svend S Geertsen, PhD, Sanofi; Hubert van Hoogstraten, MD, PhD, Sanofi; Bill Aschenbach, PhD, MBA, Sanofi; Jeffrey Chavin, MD, FAAN, Sanofi

MOC02
Psychoanalytic Telepsychology with MS Patients and Their Support People
Gayle R Lewis, Ph.D., MSCS, N/A

MOC03
Floodlight MS: Using the Jobs-to-be-Done Framework to Identify Unmet Needs in Multiple Sclerosis Care to Support Digital Medical Device Development
Jorge Cancela, PhD, MBA, Roche; Cristina Costantino, PhD, Genentech; Jumaah Goldberg, DPT, Genentech, Inc.

MOC04
Floodlight MS: Utilizing Rapid Prototyping and Human Factors Studies to Develop a Digital Medical Device for Patient-Centric MS Care
Jorge Cancela, PhD, MBA, Roche; Cristina Costantino, PhD, Genentech; Jumaah Goldberg, DPT, Genentech, Inc.; Geraint Davies, BSc, Roche; JP Guyon, MS, MBA, Roche

MOC05
Improving Communication Gaps between Physicians Who Treat MS and the Health Insurance Community
Alexis Crispino, Director of Education & Healthcare Relations (MSAA South-Central), Multiple Sclerosis Association of America; Kyle E Pinion, Senior Director of Education, Healthcare Relations & Advocacy, Multiple Sclerosis Association of America

MOC06
Remote Monitoring in MS - Initial Experience with Medical Device Icompanion
Lars Costers, PhD, icometrix, Vrije Universiteit Brussel (VUB); Annabel Descamps, MSc, icometrix; Steve De Backer, PhD, icometrix; Guy Nagels, MD PhD, icometrix, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), University of Oxford; Wim Van Hecke, PhD, icometrix; Dirk Smeets, PhD, icometrix, Vrije Universiteit Brussel (VUB)

MOC07
Development and Implementation of a Psychoeducational Model for a Pediatric MS Clinic Transition Program
Yolanda S Wheeler, PhD, CRNP, CPNP-AC, MSCN, University of Alabama at Birmingham Center for Pediatric Onset Demyelinating Disease, University of Alabama at Birmingham School of Nursing; Evelyn Hunter, PhD, Auburn University

See more of: Posters
<< Previous Session | Next Session >>